Annex Advisory Services LLC Purchases 10,900 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Annex Advisory Services LLC increased its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 43.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,080 shares of the medical instruments supplier's stock after buying an additional 10,900 shares during the quarter. Annex Advisory Services LLC's holdings in West Pharmaceutical Services were worth $10,830,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also added to or reduced their stakes in WST. Fidelis Capital Partners LLC bought a new position in shares of West Pharmaceutical Services during the first quarter valued at $27,000. Crewe Advisors LLC grew its position in shares of West Pharmaceutical Services by 322.7% in the 2nd quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier's stock valued at $31,000 after buying an additional 71 shares during the last quarter. Quarry LP increased its stake in shares of West Pharmaceutical Services by 155.3% in the fourth quarter. Quarry LP now owns 97 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 59 shares during the period. Hazlett Burt & Watson Inc. bought a new position in shares of West Pharmaceutical Services during the first quarter worth about $40,000. Finally, Northwest Investment Counselors LLC bought a new stake in West Pharmaceutical Services in the first quarter valued at approximately $40,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

West Pharmaceutical Services Trading Up 1.7 %

West Pharmaceutical Services stock traded up $4.84 during trading hours on Friday, reaching $294.91. 1,447,591 shares of the company's stock were exchanged, compared to its average volume of 454,103. The firm has a market capitalization of $21.39 billion, a PE ratio of 41.95, a PEG ratio of 10.35 and a beta of 1.01. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. The firm's 50 day simple moving average is $300.43 and its 200 day simple moving average is $328.07. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing analysts' consensus estimates of $1.74 by ($0.22). The firm had revenue of $702.10 million during the quarter, compared to the consensus estimate of $729.36 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The business's quarterly revenue was down 6.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.11 earnings per share. Research analysts predict that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

Insider Buying and Selling

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the company's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the transaction, the vice president now owns 1,478 shares in the company, valued at $443,400. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by corporate insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.